Drug-eluting Balloon is Noninferior to Drug-eluting Stent in Patients With In-stent Restenosis | DAIC
Drug-coated balloons for small coronary artery disease in patients with chronic kidney disease: a pre-specified analysis of the BASKET-SMALL 2 trial | SpringerLink
Drug-eluting balloon technology: the three components. | Download Scientific Diagram
Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus Group - ScienceDirect
Drug Eluting Balloon- Accelerating Change in Healthcare
Drug-coated Balloons for Small Coronary Vessel Interventions: A Literature Review | ICR Journal
Drug eluting balloon - YouTube
Recent FDA Approvals for Drug-eluting Balloons - Drug-eluting Balloons
Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis | Journal of the American College of Cardiology
Lepu Medical Vesselin® Drug Eluting Balloon Company, Drug Coated Balloon Coronary
Materials technology in drug eluting balloons: Current and future perspectives - ScienceDirect
Drug-Coated Balloon
Drug‑coated balloons in the treatment of acute myocardial infarction (Review)
Benefit and risk from paclitaxel-coated balloon angioplasty for the treatment of femoropopliteal artery disease: A systematic review and meta-analysis of randomised controlled trials - eClinicalMedicine
Diagnostics | Free Full-Text | The Diagnostic Value of Circulating Biomarkers and Role of Drug-Coated Balloons for In-Stent Restenosis in Patients with Peripheral Arterial Disease
Drug-eluting stent - Wikipedia
Drug-Eluting Balloons Bounce Into Global Market | DAIC
Drug-eluting Balloons Enter the U.S. Market | DAIC
Drug-Coated Balloon for Small Coronary Artery Disease in Patients With and Without High-Bleeding Risk in the BASKET-SMALL 2 Trial | Circulation: Cardiovascular Interventions